Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-001622

STANDARD BIOTOOLS INC. · LAB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
John A Levin
10% Owner · Other
Safinia Partners, L.P.
10% Owner · Other
LCS L/S, LLC
10% Owner · Other
LCS Event Partners, LLC
10% Owner · Other
LCS, LLC
10% Owner · Other
Period of report
May 7, 2018
Accepted (ET)
May 9, 2018 · 3:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F10,F3,F4May 7, 2018P38,730$5.5965A11,196,801IBy: Managed Accounts of Levin Capital Strategies, L.P.
Common StockF1,F2,F10,F6May 7, 2018P394$5.5965A90,597IBy: Bi-Directional Disequilibrium Master Fund, Ltd.
Common StockF1,F2,F10,F5May 7, 2018P5,576$5.5965A1,293,026IBy: Transamerica Large Cap Value Fund
Common StockF1,F2,F11,F3,F4May 8, 2018P29,277$5.4676A11,226,078IBy: Managed Accounts of Levin Capital Strategies, L.P.
Common StockF1,F2,F11,F6May 8, 2018P238$5.4676A90,835IBy: Bi-Directional Disequilibrium Master Fund, Ltd.
Common StockF1,F2,F11,F5May 8, 2018P3,485$5.4676A1,296,511IBy: Transamerica Large Cap Value Fund
Common StockF1,F2,F7holding———56,820IBy: Levcap Alternative Fund, L.P.
Common StockF1,F2,F8holding———19,818IBy: Safinia Partners, L.P.
Common StockF1,F2,F9holding———5,000IBy: Spouse of John A. Levin

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses